Get started
Author

Sridevi Khambhampaty

Observed name: S. Khambhampaty
ORCID: 0000-0003-2996-0235
Observed ORCID: 0000-0003-2996-0235
OpenAlex ID: A5078555704
Structural similarity, characterization of Poly Ethylene Glycol linkage and identification of product related variants in biosimilar pegfilgrastim
2019 · Rakesh Shekhawat, Chintan Kumar Shah, et al. · PLoS ONE · 23
PDF
Implementation of chemometrics, design of experiments, and neural network analysis for prior process knowledge assessment, failure modes and effect analysis, scale‐down model development, and process characterization for a chromatographic purification of Teriparatide
2022 · Mili Pathak, Prashant Pokhriyal, et al. · Biotechnology Progress · 6
Sat0451 Comparison of Pharmacokinetic, Pharmacodynamic and Safety of a Teriparatide Biosimilar and Reference Teriparatide
2020 · I. Singh, A. Attrey, et al. · Annals of the Rheumatic Diseases · 4
PDF
Phase I Study Evaluating Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Recombinant Human Serum Albumin (rHSA) in Healthy Adults
2026 · Veerendra Kumar Panuganti, Mamatha Reddy Dundigalla, et al. · Drug Design Development and Therapy · 2
PDF
A comparative multi-tiered immunogenicity assessment of biosimilar pegylated filgrastim: validation of methods for clinical assessment of INTP5
2021 · Pallavi Hajela, Ronak Patel, et al. · Expert Opinion on Biological Therapy · 1
Author response for "Implementation of chemometrics, design of experiments and neural network analysis for prior process knowledge assessment ( PPKA ), failure modes and effect analysis ( FMEA ), scale‐down model development ( SDM ) and process characterization for a chromatographic purification of Teriparatide"
2022 · Mili Pathak, Prashant Pokhriyal, et al. · Publons reviews and discussion
Author response for "Implementation of chemometrics, design of experiments and neural network analysis for prior process knowledge assessment ( PPKA ), failure modes and effect analysis ( FMEA ), scale‐down model development ( SDM ) and process characterization for a chromatographic purification of Teriparatide"
2022 · Mili Pathak, Prashant Pokhriyal, et al. · Publons reviews and discussion
Device Development for Biosimilars: Human Factor Engineering for a Teriparatide Pen
2021 · Ronak Patel, Pravin Nair, et al. · Expert Opinion on Biological Therapy
Works count: 8
Citation count: 36
H-index: 3
I10-index: 1
Year
Topic
Type